Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
Clinical Trials Related to Eosinophilic Asthma
Related studies linked through entity extraction aliases.
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Status
- RECRUITING
- Phase
- PHASE2
A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Eosinophil Subpopulations in Eosinophilic-associated Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
- Status
- RECRUITING
- Phase
- PHASE3
Phase III Long-Term Extension Study With Dexpramipexole
- Status
- TERMINATED
- Phase
- PHASE3
AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and Asthma
- Status
- UNKNOWN
- Phase
- N/A
Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
- Status
- COMPLETED
- Phase
- N/A
XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- N/A
Effect of Mepolizumab on Severe Eosinophilic Asthma
- Status
- UNKNOWN
- Phase
- N/A
Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".
- Status
- UNKNOWN
- Phase
- PHASE4
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
- Status
- RECRUITING
- Phase
- N/A
A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil
- Status
- UNKNOWN
- Phase
- PHASE4
Eosinophils Endotypes in Chronic Airway Inflammatory Diseases
- Status
- COMPLETED
- Phase
- N/A
Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE2